Longeveron (LGVN) Cash & Current Investments (2021 - 2026)

Longeveron (LGVN) recorded quarterly Cash & Current Investments of $15.8 million in Q1 2026, up 238.08% quarter-over-quarter from $4.7 million in Q4 2025, and up 9.99% on a YoY basis from $14.3 million in Q1 2025.

Longeveron (LGVN) Cash & Current Investments (2021 - 2026) Analysis & Trends

Longeveron's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $15.8 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 9.99% year-over-year to $15.8 million; the TTM figure through Mar 2026 stood at $15.8 million (up 9.99% YoY), while the FY2025 annual figure was $4.7 million, down 75.76% from the prior year.
  • Cash & Current Investments was $15.8 million for Q1 2026 at Longeveron, up from $4.7 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $22.8 million in Q3 2024 to a low of $2.3 million in Q1 2024.
  • Historically, Cash & Current Investments has averaged $10.8 million across 5 years, with a median of $9.8 million in 2025.
  • Biggest YoY gain for Cash & Current Investments was 525.36% in 2025; the steepest drop was 75.76% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $19.7 million in 2022, then slumped by 72.73% to $5.4 million in 2023, then soared by 258.74% to $19.2 million in 2024, then sank by 75.76% to $4.7 million in 2025, then soared by 238.08% to $15.8 million in 2026.
  • The last three Cash & Current Investments figures came in at $15.8 million (Q1 2026), $4.7 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 15.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.76 Mn
Dec 31, 2025 4.66 Mn
Sep 30, 2025 9.20 Mn
Jun 30, 2025 10.33 Mn
Mar 31, 2025 14.33 Mn
Dec 31, 2024 19.23 Mn
Sep 30, 2024 22.80 Mn
Jun 30, 2024 12.38 Mn
Mar 31, 2024 2.29 Mn
Dec 31, 2023 5.36 Mn
Sep 30, 2023 3.93 Mn
Jun 30, 2023 8.66 Mn
Mar 31, 2023 2.30 Mn
Dec 31, 2022 19.66 Mn
Dec 31, 2021 35.04 Mn